Investigation of Allergen Sensitization in Newborn Babies Diagnosed With Necrotizing Enterocolitis.
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age12-24
SponsorSaglik Bilimleri Universitesi
About this trial
To evaluate the frequency of allergy between 12 and 24 months of age in infants who were treated in the neonatal clinic and had NEC. To investigate the relationship between NEC development and the development of allergy in the later period.
Eligibility criteria
Qualifiers
Infants born in our hospital and diagnosed with NEC during the study period.
Age-matched control infants born in our hospital during the same period but without NEC diagnosis.
Written and verbal informed consent obtained from at least one parent.
Disqualifiers
Infants whose parents did not provide written or verbal consent.
Infants with major congenital anomalies.
Infants with chromosomal disorders.
Infants with gastrointestinal malformations (e.g., duodenal atresia, gastroschisis, omphalocele).
Trial design
Treatments tested in this trial
- skin prick test
Treatment groups
130 Participants
are divided into 2 treatment groupsLocations
This trial has no locations
Sponsors and collaborators
Saglik Bilimleri Universitesi
Lead sponsor
Source ClinicalTrials.gov